UBM Holding Nyrt

UBM Holding Nyrt has a debt-to-equity ratio of 3.31, indicating a high reliance on debt financing relative to equity. The company's current ratio of 0.9 suggests it has less current assets than current liabilities, signaling potential liquidity constraints. Operating cash flow of HUF 418.9 million is positive, but free cash flow is negative at HUF -1.43 billion, reflecting capital expenditure outpacing operating cash flow. The company's profitability metrics are weak, with a return on equity of -5.05% and a return on assets of -0.71%. These figures fall significantly below the industry median for Food Products companies, which typically report positive ROE and ROA. The net loss of HUF 501.9 million in the latest reporting period further underscores the company's underperformance relative to its peers. UBM Holding Nyrt's revenue is concentrated in feed production and distribution, grain and oilseed trade, and protein trade. The company operates primarily in the Hungarian and Central European markets, with a focus on small-scale feed products for livestock. There is no indication of geographic diversification beyond this region. The company's growth trajectory is uncertain, with no clear revenue growth or margin expansion in the latest financial period. Capital expenditure of HUF -2.18 billion indicates ongoing investment, but the negative free cash flow suggests these investments are not yet generating returns. The outlook for the current fiscal year does not include significant revenue or margin improvement. Risk factors include high leverage, with long-term debt of HUF 32.85 billion and total liabilities of HUF 61.13 billion. The company's liquidity risk is rated as medium, and its net cash position is negative after subtracting total debt. Dilution risk is currently low, but the company's negative net income and high debt load could increase the likelihood of future equity issuance. Recent events include the publication of the 2023 annual report, which details the company's financial underperformance and ongoing capital investments. No significant regulatory or operational events were disclosed in the latest filings.